In silico cancer modeling: is it ready for prime time?
- 14 October 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 6 (1) , 34-42
Abstract
In the era of personalized, systems-driven medicine, computational orin silicomodeling and the simulation of disease processes is becoming increasingly important for hypothesis generation and data integration in both experiments and clinics alike. The authors of this Review discuss selected studies on modeling malignant brain tumors and the implications for clinical practice, including trial design and outcome prediction. At the dawn of the era of personalized, systems-driven medicine, computational or in silico modeling and the simulation of disease processes is becoming increasingly important for hypothesis generation and data integration in both experiments and clinics alike. Arguably, the use of these techniques is nowhere more visible than in oncology. To illustrate the field's vast potential, as well as its current limitations, we briefly review selected studies on modeling malignant brain tumors. Implications for clinical practice, and for clinical trial design and outcome prediction, are also discussed.Keywords
This publication has 70 references indexed in Scilit:
- The human disease networkProceedings of the National Academy of Sciences, 2007
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- A Cell-Based Model Exhibiting Branching and Anastomosis during Tumor-Induced AngiogenesisBiophysical Journal, 2007
- Predictive oncology: A review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growthNeuroImage, 2007
- Computer simulation of glioma growth and morphologyNeuroImage, 2007
- Evolution of cooperation among tumor cellsProceedings of the National Academy of Sciences, 2006
- Modeling Somatic Evolution in TumorigenesisPLOS Computational Biology, 2006
- The Clinical Applications of a Systems ApproachPLOS Medicine, 2006
- A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionationJournal of Theoretical Biology, 2004
- The linear-quadratic formula and progress in fractionated radiotherapyBritish Journal of Radiology, 1989